Learn more about DEXLIFE in the Euronews science program FuturisRead more … Confronting the epidemy that is diabetes
Welcome to Dexlife
At present it is estimated that 330 million people worldwide live with type 2 diabetes and that the number will double over the next 20 years. The costs of type 2 diabetes are already huge, approaching 10% of all health costs.
Many people destined to develop type 2 diabetes spend many years in a state of pre-diabetes with abnormal blood sugar levels before they eventually develop the disease. The earlier pre-diabetes can be accurately diagnosed, the lower the resulting economic impact of diabetes.
With the support from the European Commission, DEXLIFE has been set up to investigate and prevent the progression from pre-diabetes to type 2 diabetes.